(Q61774659)
Statements
A phase II study of risk-adapted intravenous melphalan in patients with AL amyloidosis (English)
Ilona Cunningham
John Moore
Paul Cannell
Steve Gibbons
Jill Tate
Helen Mar Fan
H Miles Prince
Devinder S Gill